Singular Genomics Systems...

NASDAQ: OMIC · Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM

Singular Genomics Systems Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
52.62M 30.11M 24.11M 16.23M 33.3M 74.82M 129.28M 74.27M 93.26M 153.12M 188.57M 201.05M 239.26M 257.27M 45.53M
Short-Term Investments
61.21M 103.09M 126.63M 157.71M 157.42M 131.87M 96.79M 170.31M 170.58M 134.38M 127.4M 138.17M 117.75M 114.4M 104.59M
Long-Term Investments
n/a 600K 600K 600K 1.71M 1.71M 1.71M 1.71M 1.71M 1.73M 1.73M 687K 687K 687K 482K
Other Long-Term Assets
1.67M 1.08M 1.08M 1.75M 112K 1.22M 1.15M 2.86M 1.17M 1.18M 2.13M 1.13M 1M 990K 885K
Receivables
1.01M 1.32M 1.18M 1.58M 3.33M 697K 646K 2.01M 869K 953K 694K 1.05M n/a n/a n/a
Inventory
12.41M 12.44M 13.08M 13.57M 13.42M 14.35M 17.16M 18.22M 16.7M 12.22M 6.33M 3.01M n/a n/a n/a
Other Current Assets
268K 185K 364K 1.46M 336K 493K 472K 620K 840K 486K 503K 761K 7.21M 7.2M n/a
Total Current Assets
129.81M 148.69M 166.47M 192.23M 210.79M 225.69M 246.47M 268.43M 286.11M 305.95M 325.79M 347.76M 364.23M 378.87M 151.51M
Property-Plant & Equipment
55.07M 69.63M 70.95M 71.49M 71.9M 55.35M 56.13M 56.68M 56.48M 57.55M 12.46M 6.07M 4.92M 3.43M 2.75M
Goodwill & Intangibles
n/a n/a n/a -16.32M n/a n/a n/a -14.86M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
56.74M 71.31M 72.63M 73.24M 73.72M 58.28M 58.99M 59.54M 59.36M 60.46M 16.32M 7.89M 6.6M 5.11M 4.12M
Total Assets
186.55M 220M 239.1M 265.47M 284.52M 283.98M 305.47M 327.98M 345.48M 366.41M 342.11M 355.65M 370.83M 383.98M 155.62M
Account Payables
1.88M 1.5M 2.01M 2.59M 2.43M 1.97M 1.98M 3.1M 2.98M 4.02M 3.52M 2.35M 2.39M 2.7M 657K
Deferred Revenue
n/a n/a 3.27M 6.08M 5.06M 4.15M 3.35M 4.58M 5.48M n/a n/a n/a n/a 1.81M 2.18M
Short-Term Debt
n/a n/a n/a 7.76M 7.71M 7.61M 6.95M 6.32M 5.7M 5.24M 2.65M n/a n/a 3.47M 2.18M
Other Current Liabilities
8.79M 7.48M 4.26M -678K -3.44M -4.25M -4.48M -2.63M -1.25M -2.35M -466K 3.63M 2.97M 1.42M 4.51M
Total Current Liabilities
17.61M 16.95M 16.08M 18.29M 15.45M 13.95M 12.49M 14.12M 14.18M 13.31M 9.08M 6.74M 5.99M 8.15M 7.91M
Long-Term Debt
5.17M 6.36M 7.63M 8.9M 10.18M 10.14M 10.1M 10.06M 10.03M 9.98M 9.94M 9.9M 9.87M 6.08M 149.19M
Other Long-Term Liabilities
666K 624K 605K 650K 739K 854K 998K 1.01M 1.02M 1.16M 1.73M 2.83M 2.9M 3.17M 71.87M
Total Long-Term Liabilities
45.69M 65.35M 66.32M 68.17M 70.04M 51.64M 52.65M 53.54M 54.37M 55.54M 15.55M 12.73M 12.77M 9.25M 221.06M
Total Liabilities
63.3M 82.3M 82.4M 86.46M 85.49M 65.59M 65.14M 67.65M 68.55M 68.85M 24.63M 19.48M 18.76M 17.4M 228.97M
Total Debt
50.49M 71.79M 73.54M 75.29M 77M 58.39M 58.6M 58.84M 59.05M 59.62M 16.46M 9.9M 9.87M 9.55M 151.37M
Common Stock
n/a n/a 7K 7K 7K 7K 7K 7K 7K 7K 7K 7K 7K 7K 1K
Retained Earnings
-400.67M -383.87M -362.62M -337.6M -314.35M -291.99M -266.41M -242.78M -221.67M -197.88M -173.9M -151.9M -132.14M -114.53M -77.05M
Comprehensive Income
83K -74K -51K 155K -214K -328K -391K -837K -1.42M -1.01M -767K -138K -5K 17K -32K
Shareholders Equity
123.25M 137.71M 156.7M 179.01M 199.03M 218.39M 240.32M 260.32M 276.93M 297.56M 317.48M 336.17M 352.07M 366.58M -73.34M
Total Investments
61.21M 103.69M 127.23M 158.31M 159.13M 133.58M 98.5M 172.02M 172.29M 136.11M 129.14M 138.86M 118.44M 115.09M 105.08M